Neuway Pharma is a preclinical biotech company based in Bonn, Germany. They specialize in the development of innovative therapeutics for the treatment of brain diseases. Their focus lies in utilizing their proprietary drug delivery technology, EnPC®, to deliver these therapeutics effectively.

Established in April 2014, Neuway Pharma was the first spin-off from Life Science Inkubator (LSI) GmbH in Bonn, Germany, where it received incubation and support. The company was initially backed by Wellington Partners, LSI, Kreditanstalt für Wiederaufbau (KfW), and various private shareholders. With a dedicated Advisory Board and the support of renowned drug developers on their Scientific Board, Neuway Pharma is well-equipped to make significant advancements in the field.

They are committed to addressing the challenging nature of brain diseases and revolutionizing targeted drug delivery to improve patient outcomes. For inquiries or career opportunities, you can contact Neuway Pharma at their address: In den Dauen 6A, 53117 Bonn, Germany. You can also reach them via phone at +49 (0)228 522798-0 or fax at +49 (0)228 522798-99.

Highly skilled professionals are encouraged to apply, as Neuway Pharma values talent and expertise